Zynrelef 400-12 MG/14 ML vial 14ML
Ended Awarded
- Contract number
- SPE2DB25FJV16
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,127
Award facts
- Contract value 100% obligated
- $5,127.41 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $5,127.41 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for ZYNRELEF 400-12 mg/14 ml vials. The contract is a firm fixed-price delivery order with an ultimate completion date of September 9, 2025, and will be performed at the vendor's location in Conshohocken, Pennsylvania. This award carries no set-aside designation and was competitively awarded. ZYNRELEF is a liposomal bupivacaine and meloxicam combination product used for local infiltration anesthesia and pain management during surgical procedures, representing a specialized pharmaceutical procurement supporting federal medical supply needs.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp serves as a prime vendor for the Defense Logistics Agency's medical supply chain, providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The company's federal contracting demonstrates substantial capability in fulfilling competitive procurement requirements, delivering medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FJV16?
SPE2DB25FJV16 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 8, 2025.
How much is contract SPE2DB25FJV16 worth?
The government has obligated $5,127 on SPE2DB25FJV16.
Is contract SPE2DB25FJV16 an order under another contract?
Yes. SPE2DB25FJV16 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJV16 competed?
The extent of competition for SPE2DB25FJV16 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award